INSMED INC Payment for Debt Extinguishment or Debt Prepayment Cost
INSMED INC (INSM) reported Payment for Debt Extinguishment or Debt Prepayment Cost of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtExtinguishmentCosts · last filed 2024-02-22
- INSMED INC payment for debt extinguishment or debt prepayment cost for the quarter ending 2022-12-31 was $0.00.
- INSMED INC payment for debt extinguishment or debt prepayment cost for the quarter ending 2022-09-30 was $0.00.
- INSMED INC payment for debt extinguishment or debt prepayment cost for the quarter ending 2021-12-31 was $0.00.
- INSMED INC payment for debt extinguishment or debt prepayment cost for the quarter ending 2021-09-30 was $0.00.
- INSMED INC payment for debt extinguishment or debt prepayment cost for fiscal 2023 was $0.00.
- INSMED INC payment for debt extinguishment or debt prepayment cost for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- INSMED INC payment for debt extinguishment or debt prepayment cost for fiscal 2021 was $12.58M.
- INSMED INC payment for debt extinguishment or debt prepayment cost for fiscal 2020 was $0.00.
| Period end | Payment for Debt Extinguishment or Debt Prepayment Cost 3 month | Payment for Debt Extinguishment or Debt Prepayment Cost 3 month as first filed | Payment for Debt Extinguishment or Debt Prepayment Cost 6 month | Payment for Debt Extinguishment or Debt Prepayment Cost 6 month as first filed | Payment for Debt Extinguishment or Debt Prepayment Cost 9 month | Payment for Debt Extinguishment or Debt Prepayment Cost 9 month as first filed | Payment for Debt Extinguishment or Debt Prepayment Cost 12 month |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-22 | ||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $0.00 10-Q · filed 2022-10-27 | |||||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | ||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $12.58M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $12.58M 10-Q · filed 2022-10-27 | |||||
| 2021-06-30 | $12.58M 10-Q · filed 2022-08-04 | ||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $0.00 10-Q · filed 2021-10-28 | |||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | ||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $0.00 derived: sum of 2 quarters · filed 2022-02-17 | $0.00 derived: sum of 3 quarters · filed 2022-02-17 | $0.00 10-K · filed 2022-02-17 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $0.00 derived: sum of 2 quarters · filed 2019-10-30 | $0.00 10-Q · filed 2019-10-30 | $0.00 derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $0.00 derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-07 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $0.00 derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $2.83M 10-K · filed 2020-02-25 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $0.00 derived: sum of 2 quarters · filed 2019-10-30 | $2.83M 10-Q · filed 2019-10-30 | $2.21M 10-Q · filed 2018-10-30 | $2.83M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $2.83M 10-Q · filed 2019-08-01 | $2.21M 10-Q · filed 2018-08-02 | $2.83M derived: sum of 3 quarters · filed 2020-02-25 | $2.83M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $2.83M 10-Q · filed 2019-05-07 | $2.21M 10-Q · filed 2018-05-02 | $2.83M derived: sum of 2 quarters · filed 2020-02-25 | $2.83M derived: sum of 3 quarters · filed 2020-02-25 | $2.83M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $0.00 10-K · filed 2020-02-25 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $0.00 derived: sum of 2 quarters · filed 2018-10-30 | $0.00 10-Q · filed 2018-10-30 | ||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $0.00 10-Q · filed 2018-08-02 | |||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-02 | ||||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |